Company Search:
Advanced Search
Sponsored Links
Glycorex Transplantation AB (publ) Company Snapshot
Glycorex Transplantation AB (publ) operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Glycorex Transplantation AB (publ) with three other medical equipment manufacturers in Europe: MagForce AG of Germany (2015 sales of 2.58 million Euro [US$2.80 million] ), Scandidos AB (32.92 million Swedish Kronor [US$3.69 million] ), and Nexstim Oyj which is based in Finland (2.53 million Euro [US$2.75 million] ).

Sales Analysis. Glycorex Transplantation AB (publ) reported sales of SEK 30.11 million (US$3.38 million) for the year ending December of 2015. This represents a decrease of 10.7% versus 2014, when the company's sales were SEK 33.70 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Glycorex Transplantation AB (publ)
  Stock Performance Chart for Glycorex Transplantation AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 2.93
(Figures in Swedish Kronor)
1 Week -0.3%   13 Weeks 23.6%  
4 Weeks 46.5%   52 Weeks 66.4%  
Glycorex Transplantation AB (publ) Key Data:
  Ticker: GTAB B Country: Sweden
  Exchanges: STO Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2015 Sales 30,107,000
(Year Ending Jan 2016).
Employees: 28
  Currency: Swedish Kronor Market Cap: 194,872,706
  Fiscal Yr Ends: December Shares Outstanding: 66,509,456
  Share Type: B Aktie Closely Held Shares: 13,174,026
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.